Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
575
-
Total 13F shares, excl. options
-
184M
-
Shares change
-
+3.06M
-
Total reported value, excl. options
-
$10.1B
-
Value change
-
+$85.7M
-
Put/Call ratio
-
0.83
-
Number of buys
-
322
-
Number of sells
-
-261
-
Price
-
$54.97
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q2 2025
696 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q2 2025.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 575 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 184M shares
of 192M outstanding shares and own 96.16% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (24M shares), VANGUARD GROUP INC (19M shares), PRIMECAP MANAGEMENT CO/CA/ (15.8M shares), Dodge & Cox (15.1M shares), VIKING GLOBAL INVESTORS LP (12.3M shares), STATE STREET CORP (8.85M shares), AQR CAPITAL MANAGEMENT LLC (5.58M shares), GEODE CAPITAL MANAGEMENT, LLC (3.47M shares), MILLENNIUM MANAGEMENT LLC (2.83M shares), and MORGAN STANLEY (2.43M shares).
This table shows the top 575 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.